Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β

Mary‐Anne Hartley, Remzi Onur Eren, Matteo A. C. Rossi, Florence Prével, Patrik Castiglioni, Nathalie Isorce, Chantal Desponds, Lon‐Fye Lye, Stephen M. Beverley, Stefan K. Drexler, Nicolás FaselMicrobial 2018 · DOI

TL;DR

This study reveals that Leishmania guyanensis parasites, particularly those harboring the Leishmania RNA virus-1 (LRV1), actively evade the host's inflammasome immune response. This evasion, primarily through the endosomal TLR3 pathway and the induction of the A20 protein, appears to be a key virulence mechanism that allows the parasite to persist and cause disease.

What Problem Does This Paper Address?

Cutaneous leishmaniasis (CL), a neglected tropical disease, presents with varied clinical outcomes, from self-healing lesions to chronic, destructive forms. These outcomes are strongly linked to the host's inflammatory response. While the Leishmania parasite itself is immunogenic, the presence of the cytoplasmic Leishmania RNA virus-1 (LRV1) within L. guyanensis exacerbates inflammation and disease severity. LRV1's double-stranded RNA (dsRNA) genome is known to activate Toll-Like Receptor-3 (TLR3), a key sensor of viral RNA in endosomes. However, it was unclear which other innate immune pathways might be involved in LRV1-mediated pathology, particularly cytosolic sensors like RIG-like receptors (RLRs) and the inflammasome complex (composed of Nod-like receptors, NLRs). This paper aims to dissect the roles of these alternative pathways in L. guyanensis infection, especially in the context of LRV1 presence, to understand how the parasite manipulates the host immune system.

Methods

The researchers employed a multi-pronged approach:

  • In vitro studies: Bone marrow-derived macrophages (BMDMs) from wild-type (WT) and gene-deficient mice (e.g., MAVS-/-, ASC-/-, Caspase-1/11-/-) were infected with L. guyanensis parasites (both LRV1-positive and LRV1-negative strains) or stimulated with a synthetic TLR3 ligand (poly(I:C)). Cytokine levels (IL-6, TNF-α, IL-1β) were measured using ELISA, and protein expression of inflammasome components (caspase-1, A20) was assessed via Western blotting. Gene expression of inflammasome components and NLRs was analyzed using qRT-PCR.
  • In vivo studies: A murine model of L. guyanensis infection was established by infecting the footpads of WT and gene-deficient mice. Disease progression was monitored by measuring footpad swelling over time. Parasite burden was quantified using in vivo luminescence imaging of firefly luciferase-expressing parasites.
  • Genetic manipulation: The study utilized mice with genetic deficiencies in key inflammasome components (ASC, Caspase-1/11, IL-1β) and signaling adaptors (MAVS), as well as mice with conditional knockouts in specific cell types (dendritic cells, macrophages, keratinocytes). They also investigated the role of specific NLRs by using mice deficient in NLRC2 and NLRC5.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • LRV1's primary route: Endosomal TLR3, not cytosolic sensors. The study strongly suggests that LRV1's dsRNA genome primarily signals through the endosomal TLR3 pathway. The absence of MAVS, a crucial adaptor for cytosolic RLRs, had no impact on cytokine production or disease progression, effectively ruling out RLR involvement.
  • Inflammasome evasion is a conserved virulence strategy. L. guyanensis, regardless of LRV1 status, failed to activate the inflammasome in macrophages. This lack of activation was further supported by the absence of disease pathology changes in mice lacking key inflammasome components (ASC, Caspase-1/11). This suggests that Leishmania has evolved mechanisms to actively suppress inflammasome activation, which is a significant departure from some other Leishmania species where inflammasome activation can be protective.
  • A20: The inflammasome's saboteur. The parasite infection, especially with LRV1, led to increased expression of A20, a known inhibitor of inflammasome activation. This points to A20 as a key player in the parasite's strategy to dampen the host's inflammatory response.
  • NLRC2 emerges as a host-dependent virulence factor. While the inflammasome itself was bypassed, the study identified NLRC2 (NOD2) as an inflammasome-independent NLR that contributes to LRV1-mediated pathogenesis. Mice deficient in NLRC2 showed reduced parasite burden and lesion swelling, suggesting NLRC2 might facilitate parasite survival or disease progression through mechanisms other than direct inflammasome activation.

Key Results

  • No RLR involvement: Mice lacking MAVS showed no difference in IL-6, TNF-α production, lesional swelling, or parasite burden when infected with L. guyanensis (LRV1+ or LRV1-).
  • No inflammasome activation: L. guyanensis infection did not lead to detectable cleaved caspase-1 or IL-1β in macrophage supernatants. Mice deficient in ASC or Caspase-1/11 showed no altered disease progression or parasite burden.
  • TLR3 stimulation primes inflammasome components: Stimulation with poly(I:C) or LRV1 infection induced the transcription of inflammasome components like caspase-1, IL-1β, NLRP3, and AIM2, but not their activation.
  • A20 induction: L. guyanensis infection significantly increased A20 expression in macrophages, with LRV1+ parasites showing a more pronounced effect.
  • NLRC2 contributes to pathogenesis: Mice deficient in NLRC2 exhibited reduced lesional swelling and parasite burden upon infection with LRV1+ L. guyanensis, while NLRC5 deficiency had no significant impact.

Limitations and Future Work

  • Species-specific differences: The authors acknowledge that inflammasome activation and evasion can vary significantly between different Leishmania species and strains, potentially due to surface antigens like PSA-2. Further research is needed to understand these species-specific differences.
  • Role of GP63: While GP63, a metalloprotease on the parasite surface, has been shown in vitro to cleave inflammasome components, its in vivo role in inflammasome evasion remains to be investigated.
  • NLRC2 mechanism: The precise mechanism by which NLRC2 contributes to LRV1-mediated virulence needs further exploration. The hypothesis that NLRC2 might promote monocyte recruitment, which then serves as secondary host cells, warrants investigation.
  • Host-dependent virulence: The study suggests that NLRC2 might mediate a host-dependent virulence mechanism, distinct from LRV1's direct inflammatory effects. This opens avenues for understanding how the host's own immune components can be co-opted by the parasite.
  • CD8+ T cell role: The lack of impact of NLRC5 deficiency on disease phenotype suggests that CD8+ T cells might not play a significant role in LRV1-mediated pathology in this context, which contrasts with findings in other Leishmania infections.

Summary updated

Abstract

The various symptomatic outcomes of cutaneous leishmaniasis relates to the type and potency of its underlying inflammatory responses. Presence of the cytoplasmic <i>Leishmania</i> RNA virus-1 (LRV1) within <i>Leishmania guyanensis</i>, worsens lesional inflammation and parasite burden, as the viral dsRNA genome acts as a potent innate immunogen stimulating Toll-Like-Receptor-3 (TLR3). Here we investigated other innate pattern recognition receptors capable of reacting to dsRNA and potentially contributing to LRV1-mediated inflammatory pathology. We included the cytoplasmic dsRNA sensors, namely, the RIG-like receptors (RLRs) and the inflammasome-dependent and -independent Nod-like-receptors (NLRs). Our study found no role for RLRs or inflammasome-dependent NLRs in the pathology of <i>L. guyanensis</i> infection irrespective of its LRV1-status. Further, neither LRV1-bearing <i>L. guyanensis</i> (<i>LgyLRV1</i>+) nor LRV1-negative <i>L. guyanensis</i> (<i>LgyLRV1-</i>) activated the inflammasome <i>in vitro</i>. Interestingly, similarly to <i>L. donovani</i>, <i>L. guyanensis</i> infection induced the up-regulation of the A20 protein, known to be involved in the evasion of inflammasome activation. Moreover, we observed that <i>LgyLRV1</i>+ promoted the transcription of inflammasome-independent NLRC2 (also called NOD2) and NLRC5. However, only NLRC2 showed some contribution to LRV1-dependent pathology. These data confirmed that the endosomal TLR3 pathway is the dominant route of LRV1-dependent signalling, thus excluding the cytosolic and inflammasome pathways. We postulate that avoidance of the inflammasome pathways is likely an important mechanism of virulence in <i>Leishmania</i> infection irrespective of the LRV1-status.
BibTeX
@inproceedings{hartley2018leishmania,
  author = {Mary‐Anne Hartley and Remzi Onur Eren and Matteo A. C. Rossi and Florence Prével and Patrik Castiglioni and Nathalie Isorce and Chantal Desponds and Lon‐Fye Lye and Stephen M. Beverley and Stefan K. Drexler and Nicolás Fasel},
  title = {{Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β}},
  booktitle = {Microbial},
  year = {2018},
  doi = {10.15698/mic2018.03.619},
}
Figure